Genetic polymorphism of <i>Trypanosoma cruzi</i> bloodstream populations in adult chronic indeterminate Chagas disease patients from the E1224 clinical trial
| dc.contributor.author | Juan Carlos Ramı́rez | |
| dc.contributor.author | Gonzalo R. Acevedo | |
| dc.contributor.author | Carolina Torres | |
| dc.contributor.author | Rudy Parrado | |
| dc.contributor.author | Anabelle de la Barra | |
| dc.contributor.author | Sandro Villarroel | |
| dc.contributor.author | Lineth García | |
| dc.contributor.author | Joaquím Gascón | |
| dc.contributor.author | Lourdes Ortiz | |
| dc.contributor.author | Faustino Torrico | |
| dc.coverage.spatial | Bolivia | |
| dc.date.accessioned | 2026-03-22T15:10:59Z | |
| dc.date.available | 2026-03-22T15:10:59Z | |
| dc.date.issued | 2021 | |
| dc.description | Citaciones: 5 | |
| dc.description.abstract | Genetic variability of T. cruzi bloodstream populations during post-treatment follow-up did not differ from that observed during chronic infection in the absence of treatment, suggesting that there were no selection events of E1224-resistant parasite populations. This is the first report documenting the genetic polymorphism of natural T. cruzi populations in chronic patients in the context of clinical trials with trypanocidal drugs. | |
| dc.identifier.doi | 10.1093/jac/dkab446 | |
| dc.identifier.uri | https://doi.org/10.1093/jac/dkab446 | |
| dc.identifier.uri | https://andeanlibrary.org/handle/123456789/50865 | |
| dc.language.iso | en | |
| dc.publisher | Oxford University Press | |
| dc.relation.ispartof | Journal of Antimicrobial Chemotherapy | |
| dc.source | Experimental Medicine and Biology Institute | |
| dc.subject | Minicircle | |
| dc.subject | Biology | |
| dc.subject | Chagas disease | |
| dc.subject | Trypanosoma cruzi | |
| dc.subject | Kinetoplast | |
| dc.subject | Genetic variation | |
| dc.subject | Genetics | |
| dc.subject | Xenodiagnosis | |
| dc.subject | Immunology | |
| dc.title | Genetic polymorphism of <i>Trypanosoma cruzi</i> bloodstream populations in adult chronic indeterminate Chagas disease patients from the E1224 clinical trial | |
| dc.type | article |